← Back to Search

Behavioral Intervention

Behavioral exercise training (BET) to introduce behavioral skills for adopting an exercise program for Prostate Cancer (BETR-PC Trial)

N/A

Recruiting

Led By Alexander Lucas, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with stage II/III/IV prostate cancer

Currently undergoing treatment with ADT (intermittent or prolonged)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 8 weeks, and 12 weeks

Awards & highlights

BETR-PC Trial Summary

"This trial aims to improve an online exercise program before testing it in a bigger research study."

Who is the study for?

Men over 40 (if non-Hispanic Black or rural) or over 60 up to age 85 with stage II/III/IV prostate cancer, currently on ADT, and who've completed local treatment like surgery or radiation. They must be able to use a computer or phone for the study, speak English, and not have serious health issues that would make exercise unsafe.Check my eligibility

What is being tested?

The trial is testing a remote Behavioral Exercise Training program designed for men undergoing hormone therapy for prostate cancer. The goal is to refine this program before it's tested in a larger group of participants.See study design

What are the potential side effects?

Since the intervention involves exercise training, potential side effects may include typical exercise-related discomforts such as muscle soreness, fatigue, and risk of injury if not performed correctly.

BETR-PC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My prostate cancer is at stage II, III, or IV.

Select...

I am currently on hormone therapy for my cancer.

Select...

I have completed treatment aimed at curing my prostate cancer.

BETR-PC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 8 weeks, and 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 8 weeks, and 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 8 weeks, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the trial by assessing the retention rate

Feasibility of trial by assessing the recruitment rate

Feasibility of trial by assessing the retention rate

Secondary outcome measures

Assess disease specific quality of life (HRQL) using the 42-item Functional Assessment of Cancer Treatment-Prostate (FACT-P)

Assess health-related quality of life (HRQL) using Social Determinants of Health

Assess health-related quality of life (HRQL) using the Functional Assessment of Cancer Therapy-Fatigue scale (FACIT-fatigue)

+15 more

BETR-PC Trial Design

1Treatment groups

Experimental Treatment

Group I: Behavioral exercise training (BET) to introduce behavioral skills for adopting an exercise programExperimental Treatment1 Intervention

Single-arm, ORBIT-prospective, multicenter, nonblinded clinical trial, feasibility pilot. The BET intervention will be delivered and refined over 12 weeks. The protocol aim is to enroll men from the same representative groups of underserved men in groups of 5-10, to foster social support and group cohesion.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

NRG OncologyOTHER

231 Previous Clinical Trials

100,822 Total Patients Enrolled

19 Trials studying Prostate Cancer

12,271 Patients Enrolled for Prostate Cancer

Virginia Commonwealth UniversityLead Sponsor

699 Previous Clinical Trials

22,885,015 Total Patients Enrolled

10 Trials studying Prostate Cancer

413 Patients Enrolled for Prostate Cancer

Alexander Lucas, PhDPrincipal InvestigatorVirginia Commonwealth University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this medical study?

"Patients between the ages of 41 and 85 diagnosed with prostate cancer are eligible for enrollment in this trial, which aims to recruit approximately 30 participants."

Answered by AI

Is there an age limit for participants in this clinical study, particularly regarding individuals under 35 years of age?

"Candidates eligible for this research must be between 41 and 85 years of age. Notably, there are 72 studies focused on individuals below the age of majority and 1338 involving subjects over the age of retirement."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca

2024. "Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06250751.